Fusion Pharmaceuticals Appoints Dmitri Bobilev, M.D. as Chief Medical Officer
/PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as...
Source: prnewswire.com